Matches in SemOpenAlex for { <https://semopenalex.org/work/W2965647900> ?p ?o ?g. }
- W2965647900 endingPage "e198634" @default.
- W2965647900 startingPage "e198634" @default.
- W2965647900 abstract "Depression symptoms are present in one-third of patients with diabetes, contributing to significant adverse consequences. Population screening of high-risk patients coupled with telephone delivery of evidence-based therapies for comorbid diabetes may address barriers to care.To evaluate the effectiveness of proactive population screening plus telephone delivery of a collaborative goal-setting intervention among high-risk patients with uncontrolled diabetes and depression.In this randomized clinical trial, 225 participants (intervention [n = 136] and control [n = 89]) were enrolled from a regional Veterans Healthcare System serving Southeast Texas from November 1, 2012, through June 24, 2016. Data were gathered at baseline and 6 and 12 months after intervention. Patients selected had uncontrolled diabetes (hemoglobin A1c [HbA1c] >7.5%]) and clinically significant depression (Patient Health Questionnaire-9 scores [PHQ-9] ≥10) and were living more than 20 miles from the Veterans Affairs medical center. Data collection was completed on December 6, 2016, and final analyses were completed by January 25, 2018. All analyses were intent to treat.Healthy Outcomes Through Patient Empowerment (HOPE) included 9 telephone sessions with 24 trained health care professionals using collaborative goal-setting and behavioral activation methods. The control group received enhanced usual care (EUC) and notification of high-risk status.Change in depression symptoms using PHQ-9 and glycemic control using HbA1c from baseline to 6 months and to 12 months. Secondary analyses evaluated clinically significant responses for these measures.Among 225 participants, 202 (89.8%) were men, the mean (SD) age was 61.9 (8.3) years, 145 (64.4%) were married, and 156 (69.3%) had some education beyond high school. For the overall study, 38 participants (16.9%) were lost to follow-up or withdrew at 6 months and another 21 (9.3%) were lost to follow-up or withdrew at 12 months. Repeated-measures analysis with multiple imputation for missing data assessing the interaction of treatment group (HOPE vs EUC) and time (baseline, 6 months, and 12 months) found no significant improvement in PHQ-9 (β, 1.56; 95% CI, -0.68 to 3.81; P = .17) or HbA1c (β, -0.005; 95% CI, -0.73 to 0.72; P = .82). Analyses using t test for change from baseline to 12 months showed a HOPE vs EUC between-group mean difference for PHQ-9 of 2.14 (95% CI, 0.18 to 4.10; P = .03) and for HbA1c of -0.06% (95% CI, -0.61% to 0.50%; P = .83). A secondary analysis of patients experiencing a clinical response found that 52.1% of HOPE participants had clinically significant responses in PHQ-9 at 12 months vs 32.9% in EUC (difference, 0.19; 95% CI, 0.04-0.33; P = .01).Telephone-delivered, collaborative goal setting produced clinically significant reductions in depression symptoms but not glycemic control among patients who remained engaged at 12 months compared with EUC among a population screened sample of high-risk patients with diabetes and depression. Although the intervention created some lasting effect for depression, additional strategies are needed to maintain engagement of this high-risk population within an interprofessional team approach to primary care.ClinicalTrials.gov identifier: NCT01572389." @default.
- W2965647900 created "2019-08-13" @default.
- W2965647900 creator A5004338562 @default.
- W2965647900 creator A5021253633 @default.
- W2965647900 creator A5023049044 @default.
- W2965647900 creator A5024810233 @default.
- W2965647900 creator A5071550220 @default.
- W2965647900 creator A5072576486 @default.
- W2965647900 creator A5075661344 @default.
- W2965647900 date "2019-08-07" @default.
- W2965647900 modified "2023-10-17" @default.
- W2965647900 title "Effect of Telephone-Delivered Collaborative Goal Setting and Behavioral Activation vs Enhanced Usual Care for Depression Among Adults With Uncontrolled Diabetes" @default.
- W2965647900 cites W1764171741 @default.
- W2965647900 cites W1835344578 @default.
- W2965647900 cites W1900891786 @default.
- W2965647900 cites W1944172539 @default.
- W2965647900 cites W1967199357 @default.
- W2965647900 cites W1967547074 @default.
- W2965647900 cites W1973782829 @default.
- W2965647900 cites W1984876495 @default.
- W2965647900 cites W1985329916 @default.
- W2965647900 cites W1994336774 @default.
- W2965647900 cites W1996074019 @default.
- W2965647900 cites W2005436784 @default.
- W2965647900 cites W2018403197 @default.
- W2965647900 cites W2027540165 @default.
- W2965647900 cites W2032061858 @default.
- W2965647900 cites W2040098616 @default.
- W2965647900 cites W2041447392 @default.
- W2965647900 cites W2048921463 @default.
- W2965647900 cites W2058717577 @default.
- W2965647900 cites W2063557707 @default.
- W2965647900 cites W2064974721 @default.
- W2965647900 cites W2067411780 @default.
- W2965647900 cites W2075450487 @default.
- W2965647900 cites W2078802847 @default.
- W2965647900 cites W2088749788 @default.
- W2965647900 cites W2088834455 @default.
- W2965647900 cites W2091420496 @default.
- W2965647900 cites W2096913021 @default.
- W2965647900 cites W2099809616 @default.
- W2965647900 cites W2099888037 @default.
- W2965647900 cites W2104971784 @default.
- W2965647900 cites W2117960229 @default.
- W2965647900 cites W2129168200 @default.
- W2965647900 cites W2145365792 @default.
- W2965647900 cites W2156104108 @default.
- W2965647900 cites W2156380593 @default.
- W2965647900 cites W2161097799 @default.
- W2965647900 cites W2172193326 @default.
- W2965647900 cites W2204440170 @default.
- W2965647900 cites W2296818008 @default.
- W2965647900 cites W2298773580 @default.
- W2965647900 cites W2346963276 @default.
- W2965647900 cites W2388329775 @default.
- W2965647900 cites W2473167230 @default.
- W2965647900 cites W2494623578 @default.
- W2965647900 cites W2672694118 @default.
- W2965647900 cites W2743757382 @default.
- W2965647900 cites W2894913464 @default.
- W2965647900 cites W2895692833 @default.
- W2965647900 cites W2950918572 @default.
- W2965647900 cites W4230232512 @default.
- W2965647900 cites W4237973294 @default.
- W2965647900 cites W4238684107 @default.
- W2965647900 cites W4249999102 @default.
- W2965647900 doi "https://doi.org/10.1001/jamanetworkopen.2019.8634" @default.
- W2965647900 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6686779" @default.
- W2965647900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31390035" @default.
- W2965647900 hasPublicationYear "2019" @default.
- W2965647900 type Work @default.
- W2965647900 sameAs 2965647900 @default.
- W2965647900 citedByCount "30" @default.
- W2965647900 countsByYear W29656479002020 @default.
- W2965647900 countsByYear W29656479002021 @default.
- W2965647900 countsByYear W29656479002022 @default.
- W2965647900 countsByYear W29656479002023 @default.
- W2965647900 crossrefType "journal-article" @default.
- W2965647900 hasAuthorship W2965647900A5004338562 @default.
- W2965647900 hasAuthorship W2965647900A5021253633 @default.
- W2965647900 hasAuthorship W2965647900A5023049044 @default.
- W2965647900 hasAuthorship W2965647900A5024810233 @default.
- W2965647900 hasAuthorship W2965647900A5071550220 @default.
- W2965647900 hasAuthorship W2965647900A5072576486 @default.
- W2965647900 hasAuthorship W2965647900A5075661344 @default.
- W2965647900 hasBestOaLocation W29656479001 @default.
- W2965647900 hasConcept C118552586 @default.
- W2965647900 hasConcept C126322002 @default.
- W2965647900 hasConcept C134018914 @default.
- W2965647900 hasConcept C139719470 @default.
- W2965647900 hasConcept C162324750 @default.
- W2965647900 hasConcept C168563851 @default.
- W2965647900 hasConcept C1862650 @default.
- W2965647900 hasConcept C2775969662 @default.
- W2965647900 hasConcept C2776867660 @default.
- W2965647900 hasConcept C2778529449 @default.
- W2965647900 hasConcept C2780473172 @default.
- W2965647900 hasConcept C2780665704 @default.